Cancer Health Treatment Update Natural Killer Cells Show Promise as a New Type of Immunotherapy Two treatment approaches using donor or engineered NK cells led to remission in people with lymphoma and leukemia. KRAS Inhibitor May Offer Long-Term Benefit for Lung Cancer Patients Two-year follow-up showed that Lumakras prolonged treatment response and had a favorable safety profile. News from the American Association for Cancer Research Annual Meeting See all our reports from this major cancer research conference. When the Caregiver Becomes the Patient: Teresa’s Lung Cancer Story [SPONSORED] This sponsored article is brought to you by Merck. Experts Recommend Fifth COVID-19 Vaccination for Immunocompromised People National Comprehensive Cancer Network encourages second mRNA booster shot and offers COVID PrEP advice for people with cancer. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Advertisement Cancer Health Reader Survey Your opinion matters! Please take our survey and let Cancer Health know which topics are important to you.  Cancer Health Spring 2022 Check out our latest print edition! Newsfeed Experts Recommend Fifth COVID-19 Vaccination for Immunocompromised People Vitamin D May Protect Against Breast Cancer in Black and Latina Women Male Sex Hormones Act as New Targets for Cancer Immunotherapy Investigating the Connections Between Medicaid and Cancer Survival Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia Newsfeed Experts Recommend Fifth COVID-19 Vaccination for Immunocompromised People Vitamin D May Protect Against Breast Cancer in Black and Latina Women Male Sex Hormones Act as New Targets for Cancer Immunotherapy Investigating the Connections Between Medicaid and Cancer Survival Blog: Food and Drug Administration (FDA) FDA Approves Yescarta for Second-Line Treatment of Large B-cell Lymphoma FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: